← all drugs
Rivaroxaban For Suspension
being discontinued · Hematology · Snapshot: 2026-10-09
- Manufacturers listed
- Janssen Pharmaceuticals
- Machine-readable
- JSON for this drug
Presentations (1)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Xarelto, For Suspension, 155 mg (NDC 50458-575-01) | Janssen Pharmaceuticals | unknown | 09/18/2026 |
History
Daily tracking of this drug began 2026-09-23.
- 2026-09-23 — Rivaroxaban For Suspension appeared on the FDA shortage list (being discontinued)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.